| 1 |
30514811 | Regulated proteolysis of p62/SQSTM1 enables differential control of autophagy and nutrient sensing. | 2018 Dec 4 |
2 |
| 2 |
28489580 | Rapamycin regulates macrophage activation by inhibiting NLRP3 inflammasome-p38 MAPK-NFκB pathways in autophagy- and p62-dependent manners. | 2017 Jun 20 |
2 |
| 3 |
28575052 | Myogenic differentiation of VCP disease-induced pluripotent stem cells: A novel platform for drug discovery. | 2017 |
2 |
| 4 |
29152091 | Fibroblast growth factor-2-mediated protection of cardiomyocytes from the toxic effects of doxorubicin requires the mTOR/Nrf-2/HO-1 pathway. | 2017 Oct 20 |
2 |
| 5 |
25884947 | Rapamycin and chloroquine: the in vitro and in vivo effects of autophagy-modifying drugs show promising results in valosin containing protein multisystem proteinopathy. | 2015 |
2 |
| 6 |
25150927 | Axonal protection by modulation of p62 expression in TNF-induced optic nerve degeneration. | 2014 Oct 3 |
1 |
| 7 |
24184927 | Increased autophagy accelerates colchicine-induced muscle toxicity. | 2013 Dec |
1 |
| 8 |
22995302 | SIRT1 inactivation induces inflammation through the dysregulation of autophagy in human THP-1 cells. | 2012 Oct 12 |
2 |
| 9 |
20600853 | p62 (SQSTM1) and cyclic AMP phosphodiesterase-4A4 (PDE4A4) locate to a novel, reversible protein aggregate with links to autophagy and proteasome degradation pathways. | 2010 Oct |
1 |